NORMAN PANG: Open Payments
NPI 1861434367 · PETALUMA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,309 in 48 payments from 9 companies in 2025. Trend: 2023 $487 · 2024 $601 · 2025 $1,309
Food & beverage: $713Travel & lodging: $596
| Company | Payments | Amount |
|---|---|---|
| SI-BONE, INC. | 4 | $633 |
| Collegium Pharmaceutical, Inc. | 19 | $166 |
| Electronic Waveform Lab, Inc. | 8 | $126 |
| ABBVIE INC. | 4 | $106 |
| VERTEX PHARMACEUTICALS INCORPORATED | 4 | $100 |
| SCILEX PHARMACEUTICALS INC. | 5 | $91 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $46 |
| Forte Bio-Pharma LLC | 1 | $21 |
| Virtus Pharmaceuticals LLC | 1 | $20 |
Products named: IFUSE IMPLANT SYSTEM, Belbuca, JOURNAVX, QULIPTA, ZTLido, RELISTOR, UBRELVY, PROLATE.
Industry payments across CA — which companies pay providers there.
